BOSTON—Metabolic dysfunction–associated steatohepatitis is a growing concern in the pediatric population, with young adults with MASH now the fastest-growing population requiring liver transplant. At The Liver Meeting 2023, experts discussed how to help young patients transfer from pediatric to adult hepatology care.
According to a recent study of steatosis and fibrosis in young adults, the prevalence of metabolic dysfunction–associated steatotic liver disease is 23.2%, and